“Postoperative Cognitive Dysfunction in the Elderly: A Role for Modafinil”, 2022-06-22 ():
Backgroundː Postoperative cognitive dysfunction has long-term consequences of increased mortality, loss of autonomy, and prolonged hospitalization. We sought to determine whether exposing patients to modafinil may attenuate or prevent this devastating syndrome from affecting the elderly postoperatively.
Methodː Adults aged 65 and older and American Society of Anesthesiologists (ASA) I-III physical status scheduled for elective non-cardiac/non-neurosurgical surgery were included. Subjects were tested with the Trail Making Test (TMT) and Rey Auditory Visual Learning Test (RAVLT) preoperatively as well as in the immediate postoperative period, at 1 week, and at 3 months. After baseline testing, patients were randomized into 3 groups: (0) placebo pre/post-procedure; (1) modafinil only pre-procedure and placebo post-procedure; and (2) modafinil pre/post-procedure. A nonsurgical control group was also used.
Resultsː 76 subjects completed the trial 3 months post-surgery. The baseline RAVLT obtained was analyzed with 2-way ANOVA with repeated measures and showed improvement in learning in all groups (p = 0.03). At 1-week post-surgery, Group 0 subjects demonstrated no learning improvement in the RAVLT. However, there was a statistically-significant improvement in learning in both groups that received modafinil (p < 0.01), and in the nonsurgical controls (p < 0.01). This learning benefit normalized at 3 months.
Conclusionː In this prospective, double-blind, placebo-controlled trial, we found that patients who received modafinil showed improvement in the RAVLT at 1 week. However, this learning benefit normalized at 3 months. Further study should examine dose effect, timing, and route of administration to determine if the effect can be enhanced and if in fact, wakefulness is improved post-surgically.